Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

With their help, we were able to identify a specific TMEM16F mutation which is common in Ashkenazi Jews in general ... new ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev ... The most common ones include skin reactions where the injection ...

Can a common parasite help treat Alzheimer’s? Scientists say Toxoplasma gondii may open pathways to brain therapies for ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

Parkinson's disease is the second most common neurodegenerative disorder after Alzheimer's. It is the fastest growing condition of its type in the world and, although there are treatments to ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

Designed for patients, caregivers, and anyone interested in Parkinson’s disease, this free event is open to the public with ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...